NCT05620641View on ClinicalTrials.gov

Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

April 1, 2025

Conditions
Post Operative Nausea and VomitingSleeve GastrectomyMorbid Obesity
Interventions
DRUG

Ondansetron 8mg

50 patients will receive intravenous ondansetron 8 mg before the end of surgery.

DRUG

Gabapentin

50 patients will receive 600 mg oral gabapentin 1 h before anesthesia.

Trial Locations (1)

31111

Gastrointestinal and Laparoscopic Surgery Unit, General Surgery Department, Tanta University Hospital, Tanta, Egypt, Tanta

All Listed Sponsors
lead

Tanta University

OTHER